pirfenidone modified release
/ Overseas Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
March 20, 2025
Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions
(clinicaltrials.gov)
- P1 | N=18 | Completed | Sponsor: Overseas Pharmaceuticals, Ltd. | Not yet recruiting ➔ Completed
Trial completion • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
September 20, 2024
YY-BFNT-2023: Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: Overseas Pharmaceuticals, Ltd.
New P1 trial • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
September 19, 2024
Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions
(clinicaltrials.gov)
- P1 | N=12 | Completed | Sponsor: Overseas Pharmaceuticals, Ltd.
New P1 trial • Idiopathic Pulmonary Fibrosis • Immunology • Pulmonary Disease • Respiratory Diseases
1 to 3
Of
3
Go to page
1